Android app on Google Play

UPDATE: MKM Partners Upgrades Infinera Corporation (INFN) to Buy

February 4, 2013 7:38 AM EST Send to a Friend
(Updated - February 4, 2013 9:27 AM EST)

(correction) MKM Partners upgraded Infinera Corporation (INFN) from Neutral to Buy.

For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.

Shares of Infinity Pharmaceutical closed at $34.12 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Add Your Comment